Recent Quotes
View Full List
My Watchlist
Everpure, Inc. Class A common stock
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
Goldman Sachs Future Tech Leaders Equity ETF
Ishares Core Equity ETF
ProShares Equities for Rising Rates ETF
Reneuron Group Plc
Tradr 2X Long SPY Monthly ETF
Tuttle Capital Photonics Income Blast ETF
Tuttle Capital Pure Play Photonics ETF
iShares S&P 500 Growth ETF
iShares S&P 500 Value ETF
Edit Watchlist
Indicators
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Incyte and Mirati
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement to Evaluate INCB99280 and Adagrasib in Patients with KRASG12C-Mutated Solid Tumors
November 07, 2022
From
Incyte and Mirati
Via
Business Wire
Tickers
INCY
MRTX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.